Causes of death and mortality patterns in clozapine-treated patients: 17-year retrospective cohort study
BJPsych Open · 2026-09 · 12 (5)
DOI: 10.1192/bjo.2026.12069 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift BJPsych Open, online erschienen am 10.08.2026. Verfasst von Mar Alonso-Garcia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Gregorio Marañón General University Hospital, Madrid, Spain. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Clozapine reduces overall mortality and suicide risk in schizophrenia, but the specific causes and clinical contexts of death among clozapine-treated patients remain less well characterised.
Aims
We aimed to characterise causes of death in clozapine-treated patients within a defined UK catchment area over 17 years (2009–2025); compare features across predefined mortality clusters (suicide, expected, unexpected); compare unexpected death cases with a clozapine-treated comparison cohort alive in 2019 and examine temporal mortality patterns.
Method
We conducted a retrospective, descriptive cohort study of all deaths among clozapine-treated patients within a UK mental health National Health Service Trust between 1 January 2009 and 31 December 2025. Deaths were classified into suicide, expected and non-intentional unexpected, using a previously established framework. Variables were compared across clusters and between unexpected death cases and a clozapine-treated comparison cohort alive in 2019.
Results
Of 87 deaths, 11 (12.6%) were suicides, 29 (33.3%) were expected and 47 (54.0%) were non-intentional unexpected. Malignancy was the most common cause (21/87, 24.1%), followed by cardiovascular (13/87, 14.9%) and respiratory or infective causes (9/87, 10.3%). Age differed across clusters ( p = 0.005), with suicides at younger ages. Compared with the 2019 cohort, patients who died unexpectedly were older (55.0 v . 48.6 years, p = 0.006) and more likely to smoke (75.0 v . 34.6%, p < 0.001). Annual mortality peaked in 2021 and was not fully explained by direct COVID-19 deaths.
Conclusions
Mortality in clozapine-treated patients arises across diverse clinical contexts, with more than half classified as non-intentional unexpected. Findings support sustained physical health monitoring, closer attention to smoking and other modifiable risks, and continuity of care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Gregorio Marañón General University Hospital, Madrid, Spain.
- Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
- Department of Psychiatry, University of Cambridge, UK.
- IdiPAZ, School of Medicine, University Hospital La Paz, The Autonomous University of Madrid, CIBERSAM, Madrid, Spain.
ORCID-Profile: Rajeev Krishnadas, Emilio Fernandez-Egea
Zitieren
APA
Alonso-Garcia, M., Seabright, D., Achakzai, G. M., Ali, A., Krishnadas, R., Cardinal, R. N., Jenkins, C., Arango, C., & Fernandez-Egea, E. (2026). Causes of death and mortality patterns in clozapine-treated patients: 17-year retrospective cohort study. BJPsych Open, 12(5). https://doi.org/10.1192/bjo.2026.12069
Vancouver
Alonso-Garcia M, Seabright D, Achakzai GM, Ali A, Krishnadas R, Cardinal RN, et al. Causes of death and mortality patterns in clozapine-treated patients: 17-year retrospective cohort study. BJPsych Open. 2026;12(5). doi:10.1192/bjo.2026.12069
BibTeX
@article{AlonsoGarcia2026,
author = {Alonso-Garcia, Mar and Seabright, David and Achakzai, Guluno Malik and Ali, Amina and Krishnadas, Rajeev and Cardinal, Rudolf N and Jenkins, Christoper and Arango, Celso and Fernandez-Egea, Emilio},
title = {Causes of death and mortality patterns in clozapine-treated patients: 17-year retrospective cohort study},
journal = {BJPsych Open},
year = {2026},
volume = {12},
number = {5},
doi = {10.1192/bjo.2026.12069}
}
EUVIMED